995
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Cloning, characterization, and inhibition of the novel β-carbonic anhydrase from parasitic blood fluke, Schistosoma mansoni

ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Article: 2184299 | Received 16 Jan 2023, Accepted 14 Feb 2023, Published online: 01 Mar 2023

References

  • Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006;368(9541):1106–1118.
  • McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Prim. 2018;4(1).
  • Kamau E, Yates A, Maisiba R, Singoei V, Opot B, Adeny R, Arima CO, Otieno V, Sumbi CS, Okoth RO, et al. Epidemiological and clinical implications of asymptomatic malaria and schistosomiasis co-infections in a rural community in western Kenya. BMC Infect Dis. 2021;21(1).
  • Wilson S, Vennervald BJ, Dunne DW. Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria. PLOS Negl Trop Dis. 2011;5(8):e1149.
  • Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012;26(2):383–397.
  • Elbaz T, Esmat G. Hepatic and intestinal schistosomiasis: review. J Adv Res. 2013;4(5):445–452.
  • Nelwan ML. Schistosomiasis: life cycle, diagnosis, and control. Curr Ther Res Clin Exp. 2019;91:5–9.
  • Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253–2264.
  • Costain AH, MacDonald AS, Smits HH. Schistosome egg migration: mechanisms, pathogenesis and host immune responses. Front Immunol. 2018;9.
  • Siqueira L. d P, Fontes DAF, Aguilera CSB, Timóteo TRR, Ângelos MA, Silva LCPBB, de Melo CG, Rolim LA, da Silva RMF, Neto PJR, et al. Schistosomiasis: drugs used and treatment strategies. Acta Trop. 2017;176:179–187.
  • Gasim GI, Bella A, Adam I. Schistosomiasis, hepatitis B and hepatitis C co-infection. Virol J. 2015;12(1).
  • Rahmani A, Baee M, Rostamtabar M, Karkhah A, Alizadeh S, Tourani M, Nouri HR. Development of a conserved chimeric vaccine based on helper T-cell and CTL epitopes for induction of strong immune response against Schistosoma mansoni using immunoinformatics approaches. Int J Biol Macromol. 2019;141:125–136.
  • Eyayu T, Zeleke AJ, Worku L. Current status and future prospects of protein vaccine candidates against Schistosoma mansoni infection. Parasite Epidemiol Control. 2020;11:e00176.
  • LoVerde PT. Schistosomiasis. Adv Exp Med Biol. 2019;1154:45–70.
  • Cioli D, Pica-Mattoccia L, Basso A, Guidi A. Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol. 2014;195(1):23–29.
  • Doenhoff MJ, Kusel JR, Coles GC, Cioli D. Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg. 2002;96(5):465–469.
  • Botros SS, Bennett JL. Praziquantel resistance. Expert Opin Drug Discov. 2007;2(sup1):S35–S40.
  • Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat. 2013;23(6):693–704.
  • Bonardi A, Vermelho AB, da Silva Cardoso V, de Souza Pereira MC, da Silva Lara L, Selleri S, Gratteri P, Supuran CT, Nocentini A. N-nitrosulfonamides as carbonic anhydrase inhibitors: a promising chemotype for targeting Chagas disease and Leishmaniasis. ACS Med Chem Lett. 2019;10(4):413–418.
  • D'Ambrosio K, Supuran CT, De Simone G. Are carbonic anhydrases suitable targets to fight protozoan parasitic diseases? Curr Med Chem. 2018;25(39):5266–5278.
  • Liljas A, Laurberg M. A wheel invented three times. The molecular structures of the three carbonic anhydrases. EMBO Rep. 2000;1(1):16–17.
  • De Simone G, Di Fiore A, Capasso C, Supuran CT. The zinc coordination pattern in the η-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families. Bioorg Med Chem Lett. 2015;25(7):1385–1389.
  • Jensen EL, Clement R, Kosta A, Maberly SC, Gontero B. A new widespread subclass of carbonic anhydrase in marine phytoplankton. ISME J. 2019;13(8):2094–2106.
  • Cox EH, McLendon GL, Morel FM, Lane TW, Prince RC, Pickering IJ, George GN. The active site structure of Thalassiosira weissflogii carbonic anhydrase 1. Biochemistry. 2000;39(40):12128–12130.
  • Del Prete S, Vullo D, De Luca V, Supuran CT, Capasso C. Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA. J Enzyme Inhib Med Chem. 2014;29(6):906–911.
  • Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma- carbonic anhydrases from bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem. 2015;30(2):325–332.
  • Zolfaghari Emameh R, Kuuslahti M, Nosrati H, Lohi H, Parkkila S. Assessment of databases to determine the validity of β-A nd γ-carbonic anhydrase sequences from vertebrates. BMC Genomics. 2020;21(1):352.
  • Ferry JG. The γ class of carbonic anhydrases. Biochim Biophys Acta Proteins Proteomics. 2010;1804(2):374–381.
  • Alterio V, Langella E, Viparelli F, Vullo D, Ascione G, Dathan NA, Morel FMM, Supuran CT, De Simone G, Monti SM. Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii. Biochimie. 2012;94(5):1232–1241.
  • Park H, Song B, Morel FMM. Diversity of the cadmium-containing carbonic anhydrase in marine diatoms and natural waters. Environ Microbiol. 2007;9(2):403–413.
  • Chasen NM, Asady B, Lemgruber L, Vommaro RC, Kissinger JC, Coppens I, Moreno SNJ. A glycosylphosphatidylinositol-anchored carbonic anhydrase-related protein of Toxoplasma gondii is important for rhoptry biogenesis and virulence. mSphere. 2017;2(3).
  • Kikutani S, Nakajima K, Nagasato C, Tsuji Y, Miyatake A, Matsuda Y. Thylakoid luminal Θ-carbonic anhydrase critical for growth and photosynthesis in the marine diatom Phaeodactylum tricornutum. Proc Natl Acad Sci USA. 2016;113(35):9828–9833.
  • Angeli A, Berrino E, Carradori S, Supuran CT, Cirri M, Carta F, Costantino G. Amine- and amino acid-based compounds as carbonic anhydrase activators. Molecules. 2021;26(23):7331.
  • Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST, Al-Lazikani B, Andrade LF, Ashton PD, et al. The genome of the blood fluke Schistosoma mansoni. Nature. 2009;460(7253):352–358.
  • Da’dara AA, Angeli A, Ferraroni M, Supuran CT, Skelly PJ. Crystal structure and chemical inhibition of essential schistosome host-interactive virulence factor carbonic anhydrase SmCA. Commun Biol. 2019;2(1).
  • Ferraroni M, Angeli A, Carradori S, Supuran CT. Inhibition of Schistosoma mansoni carbonic anhydrase by the antiparasitic drug clorsulon: X-ray crystallographic and in vitro studies. Acta Crystallogr D Struct Biol. 2022;78(Pt 3):321–327.
  • Supuran CT, Altamimi ASA, Carta F. Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013–2019. Expert Opin Ther Pat. 2019;29(10):781–792.
  • Lomelino C, McKenna R. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011–2016). Expert Opin Ther Pat. 2016;26(8):947–956.
  • Li Y, Zhang Y, Zhang Y. Research advances in pathogenesis and prophylactic measures of acute high altitude illness. Respir Med. 2018;145:145–152.
  • Imray C, Wright A, Subudhi A, Roach R. Acute mountain sickness: pathophysiology, prevention, and treatment. Prog Cardiovasc Dis. 2010;52(6):467–484.
  • Davis C, Hackett P. Advances in the prevention and treatment of high altitude illness. Emerg Med Clin North Am. 2017;35(2):241–260.
  • Supuran CT. Advances in structure-based drug discovery of carbonic anhydrase inhibitors. Expert Opin Drug Discov. 2017;12(1):61–88.
  • Supuran CT. Carbonic anhydrase inhibitors and their potential in a range of therapeutic areas. Expert Opin Ther Pat. 2018;28(10):709–712.
  • McKenna R, Supuran CT. Carbonic anhydrase inhibitors drug design. Subcell Biochem. 2014;75:291–323.
  • Supuran CT. Novel carbonic anhydrase inhibitors. Future Med Chem. 2021;13(22):1935–1937.
  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008;7(2):168–181.
  • Emameh RZ, Syrjänen L, Barker H, Supuran CT, Parkkila S. Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests. J Enzyme Inhib Med Chem. 2015;30(3):505–513.
  • Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using clustal omega. Mol Syst Biol. 2011;7(1):539.
  • Madeira F, Pearce M, Tivey ARN, Basutkar P, Lee J, Edbali O, Madhusoodanan N, Kolesnikov A, Lopez R. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res. 2022;50(W1):W276–W279.
  • Gouy M, Guindon S, Gascuel O. Sea view version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol. 2010;27(2):221–224.
  • Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res. 2004;14(6):1188–1190.
  • Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42(W1):W320–W324.
  • Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, Yuan D, Stroe O, Wood G, Laydon A, et al. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50(D1):D439–D444.
  • Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–589.
  • Evans R, O’Neill M, Pritzel A, et al. Protein complex prediction with AlphaFold-Multimer. bioRxiv. 2021:2021.10.04.463034.
  • Naville M, Ghuillot-Gaudeffroy A, Marchais A, Gautheret D. ARNold: a web tool for the prediction of rho-independent transcription terminators. RNA Biol. 2011;8(1):11–13.
  • Urbański LJ, Di Fiore A, Azizi L, Hytönen VP, Kuuslahti M, Buonanno M, Monti SM, Angeli A, Zolfaghari Emameh R, Supuran CT, et al. Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase from Trichomonas vaginalis. J Enzyme Inhib Med Chem. 2020;35(1):1292–1299.
  • Haapanen S, Bua S, Kuuslahti M, Parkkila S, Supuran CT. Cloning, characterization and anion inhibition studies of a β-carbonic anhydrase from the pathogenic protozoan Entamoeba histolytica. Molecules. 2018;23(12):3112.
  • Kopp J, Slouka C, Ulonska S, Kager J, Fricke J, Spadiut O, Herwig C. Impact of glycerol as carbon source onto specific sugar and inducer uptake rates and inclusion body productivity in E. coli BL21(DE3). Bioengineering. 2017;5(1):1.
  • Khalifah RG. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J Biol Chem. 1971;246(8):2561–2573.
  • Berrino E, Bua S, Mori M, Botta M, Murthy VS, Vijayakumar V, Tamboli Y, Bartolucci G, Mugelli A, Cerbai E, et al. Novel sulfamide-containing compounds as selective carbonic anhydrase I inhibitors. Molecules. 2017;22(7):1049.
  • Urbanski LJ, Bua S, Angeli A, Kuuslahti M, Hytönen VP, Supuran CT, Parkkila S. Sulphonamide inhibition profile of Staphylococcus aureus β-carbonic anhydrase. J Enzyme Inhib Med Chem. 2020;35(1):1834–1839.
  • Bua S, Haapanen S, Kuuslahti M, Parkkila S, Supuran CT. Sulfonamide inhibition studies of a new β-carbonic anhydrase from the pathogenic protozoan entamoeba histolytica. Int J Mol Sci. 2018;19(12):3946.
  • Kimber MS, Pai EF. The active site architecture of Pisum sativum beta-carbonic anhydrase is a mirror image of that of alpha-carbonic anhydrases. EMBO J. 2000;19(7):1407–1418.
  • Vale N, Gouveia MJ, Rinaldi G, Brindley PJ, Gärtner F, Da Costa JMC. Praziquantel for schistosomiasis: single-drug metabolism revisited, mode of action, and resistance. Antimicrob Agents Chemother. 2017;61(5).
  • Li EY, Gurarie D, Lo NC, Zhu X, King CH. Improving public health control of schistosomiasis with a modified WHO strategy: a model-based comparison study. Lancet Glob Health. 2019;7(10):e1414–e1422.
  • Wang W, Wang L, Liang YS. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res. 2012;111(5):1871–1877.
  • Syrjänen L, Vermelho AB, Rodrigues I. d A, Corte-Real S, Salonen T, Pan P, Vullo D, Parkkila S, Capasso C, Supuran CT. Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. J Med Chem. 2013;56(18):7372–7381.
  • Zolfaghari Emameh R, Kuuslahti M, Vullo D, Barker HR, Supuran CT, Parkkila S. Ascaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis. Parasites Vectors. 2015;8(1).
  • Khubchandani IT, Bub DS. Parasitic infections. Clin Colon Rectal Surg. 2019;32(5):364–371.
  • Mansour NS, Youssef FG, Mikhail EM, Mohareb EW. Amebiasis in schistosomiasis endemic and non-endemic areas in Egypt. J Egypt Soc Parasitol. 1997;27(3):617–628.
  • Dolabella SS, Coelho PMZ, Borçari IT, Mello NAST, Andrade ZDA, Silva EF. Morbidity due to Schistosoma mansoni – Entamoeba histolytica coinfection in hamsters (Mesocricetus auratus). Rev Soc Bras Med Trop. 2007;40(2):170–174.
  • Gulati S, Aref AA. Oral acetazolamide for intraocular pressure lowering: balancing efficacy and safety in ophthalmic practice. Expert Rev Clin Pharmacol. 2021;14(8):955–961.
  • Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol. 2007;102(4):1313–1322.
  • Adamson R, Swenson ER. Acetazolamide use in severe chronic obstructive pulmonary disease pros and cons. Ann Am Thorac Soc. 2017;14(7):1086–1093.
  • Van Berkel MA, Elefritz JL. Evaluating off-label uses of acetazolamide. Am J Health Syst Pharm. 2018;75(8):524–531.
  • Cong-Hui Z, Huai-Min Z. Cloning and characterization of β-carbonic anhydrase, a potential drug target of Schistosoma japonicum. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016;28(2):161–166.
  • Llanwarne F, Helmby H. Granuloma formation and tissue pathology in Schistosoma japonicum versus Schistosoma mansoni infections. Parasite Immunol. 2021;43(2):e12778.